  | Hubaux, R., Vandermeers, F., Cosse, J.-P., Crisanti, C., Kapoor, V., Albelda, S. M., Mascaux, C., Delvenne, P., Hubert, P., & Willems, L. (19 October 2015). Valproic acid improves second-line regimen of small cell lung carcinoma in preclinical models. ERJ Open Research, 1 (2), 00028. doi:10.1183/23120541.00028-2015  Peer Reviewed verified by ORBi |
 | Gillet, N., Vandermeers, F., De Brogniez, A., Florins, A., Nigro, A., François, C., Bouzar, A.-B., Verlaeten, O., Stern, E., Lambert, D., Wouters, J., & Willems, L. (2012). Chemoresistance to Valproate Treatment of Bovine Leukemia Virus-Infected Sheep; Identification of Improved HDAC Inhibitors. Pathogens, (2012-1), 65-82. doi:10.3390/pathogens1020065 Peer Reviewed verified by ORBi |
 | Hubaux, R., Vandermeers, F., Crisanti, C., Kapoor, V., Burny, A., Mascaux, C., Albelda, S. M., & Willems, L. (09 June 2010). Preclinical evidence for a beneficial impact of valproate on the response of small cell lung cancer to first-line chemotherapy. European Journal of Cancer, 46, 1724-1734. doi:10.1016/j.ejca.2010.03.021 Peer Reviewed verified by ORBi |
  | Crisanti, C., Wallace, A., Kapoor, V., Vandermeers, F., Dowling, M., Pereira, L., Coleman, K., Campling, B., Fridlender, Z., Kao, G., & Albelda, S. (August 2009). The HDAC inhibitor panobinostat (LBH589) inhibits mesothelioma and lung cancer cells in vitro and in vivo with particular efficacy for small cell lung cancer. Molecular Cancer Therapeutics, 8 (8), 2221-2231. doi:10.1158/1535-7163.MCT-09-0138 Peer Reviewed verified by ORBi |
 | Vandermeers, F., Hubert, P., Delvenne, P., Mascaux, C., Grigoriu, B., Burny, A., Scherpereel, A., & Willems, L. (2009). Valproate, in combination with pemetrexed and cisplatin, provides additional efficacy to the treatment of malignant mesothelioma. Clinical Cancer Research, 15 (8), 2818-28. doi:10.1158/1078-0432.CCR-08-1579 Peer Reviewed verified by ORBi |
 | Vandermeers, F., Kettmann, R., & Willems, L. (2008). Implication des modifications épigénétiques dans les cancers : développement de nouvelles approches thérapeutiques. Biotechnologie, Agronomie, Société et Environnement, 12 (2). Peer Reviewed verified by ORBi |
 | Florins, A.-F., Boxus, M., Vandermeers, F., Verlaeten, O., Bouzar, A., Defoiche, J., Hubaux, R., Burny, A., Kettmann, R., & Willems, L. (2008). Emphasis on cell turnover in two hosts infected by bovine leukemia virus: a rationale for host susceptibility to disease. Veterinary Immunology and Immunopathology, 125 (1-2), 1-7. doi:10.1016/j.vetimm.2008.04.007 Peer Reviewed verified by ORBi |
 | Florins, A.-F., Gillet, N., Boxus, M., Verlaeten, O., Nigro, A., Vandermeers, F., Burteau, C., Balon, H., Bouzar, A., Defoiche, J., Burny, A., Kettmann, R., & Willems, L. (2007). Dynamique cellulaire de la pathogenèse induite par le virus de la leucémie bovine. Virologie. doi:10.1684/vir.2007.0134 Peer reviewed |
 | Florins, A.-F., Gillet, N., Asquith, B., Boxus, M., Burteaux, C., Twizere, J.-C., Urbain, P., Vandermeers, F., Debacq, C., Sanchez-alcaraz, M. T., Schwartz-Cornil, I., Kerkhofs, P., Jean, G., Thewis, A., Hay, J., Mortreux, F., Wattel, E., Reichert, M., Burny, A., ... Willems, L. (2007). Cell dynamics and immune response to BLV infection: a unifying model. Frontiers in Bioscience: A Journal and Virtual Library, 12, 1520-1531. doi:10.2741/2165 Peer Reviewed verified by ORBi |
 | Gillet, N., Florins, A.-F., Boxus, M., Burteau, C., Nigro, A., Vandermeers, F., Balon, H., Bouzar, A., Defoiche, J., Burny, A., Reichert, M., Kettmann, R., & Willems, L. (2007). Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in human. Retrovirology, 4 (1), 18. doi:10.1186/1742-4690-4-18 Peer Reviewed verified by ORBi |
 | Achachi, A.* , Florins, A.-F.* , Gillet, N.* , Debacq, C., Urbain, P., Foutsop, G. M., Vandermeers, F., Jasik, A., Reichert, M., Kerkhofs, P., Lagneaux, L., Burny, A., Kettmann, R., & Willems, L. (2005). Valproate activates bovine leukemia virus gene expression, triggers apoptosis, and induces leukemia/lymphoma regression in vivo. Proceedings of the National Academy of Sciences of the United States of America, 102 (29), 10309-14. doi:10.1073/pnas.0504248102 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |